These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3057655)

  • 1. Warfarin bio-availability. A comparison of 4 products.
    Müller FO; Steyn JM; Hundt HK; Luus HG
    S Afr Med J; 1988 Dec; 74(11):566-7. PubMed ID: 3057655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No effect of encapsulation on the pharmacokinetics of warfarin.
    Johansson S; Ohlsson L; Stenhoff H; Wåhlander K; Cullberg M
    Biopharm Drug Dispos; 2005 Apr; 26(3):121-7. PubMed ID: 15751004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bio-availability of four formulations of furosemide.
    Meyer BH; Müller FO; Swart KJ; Luus HG; Werkman IM
    S Afr Med J; 1985 Oct; 68(9):645-7. PubMed ID: 3904040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of a pharmacokinetic interaction between etanercept and warfarin.
    Zhou H; Patat A; Parks V; Buckwalter M; Metzger D; Korth-Bradley J
    J Clin Pharmacol; 2004 May; 44(5):543-50. PubMed ID: 15102876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of lacosamide on the pharmacokinetic and pharmacodynamic profiles of warfarin.
    Stockis A; van Lier JJ; Cawello W; Kumke T; Eckhardt K
    Epilepsia; 2013 Jul; 54(7):1161-6. PubMed ID: 23614393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penbutolol and furosemide in a fixed-dose combination-bio-equivalence of two formulations.
    Meyer BH; Müller FO; Hundt HK; Grigoleit HG; Hajdu P; Heptner W
    S Afr Med J; 1981 Jun; 59(25):891-3. PubMed ID: 7015536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers.
    Kanjanawart S; Gaysonsiri D; Phunikom K; Simasathiansopon S; Tangsucharit P; Vannaprasaht S; Kaewkamson T; Tassaneeyakul W
    Int J Clin Pharmacol Ther; 2013 Mar; 51(3):249-54. PubMed ID: 23357835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bio-availability of three formulations of glibenclamide.
    Meyer BH; Müller FO; Luus HG; Eckert HG
    S Afr Med J; 1989 Aug; 76(4):146-7. PubMed ID: 2503895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the bioavailabilities and anticoagulant activities of two warfarin formulations.
    Stirling Y; Howarth DJ; Stockley R; Bland R; Towler CM; Harding SM
    Br J Haematol; 1982 May; 51(1):37-46. PubMed ID: 7073989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability study of two cefixime formulations administered orally in healthy male volunteers.
    Zakeri-Milani P; Valizadeh H; Islambulchilar Z
    Arzneimittelforschung; 2008; 58(2):97-100. PubMed ID: 18412024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and warfarin in healthy volunteers.
    Macha S; Rose P; Mattheus M; Pinnetti S; Woerle HJ
    Diabetes Obes Metab; 2013 Apr; 15(4):316-23. PubMed ID: 23094794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of interaction between famotidine and warfarin.
    De Lepeleire I; Van Hecken A; Verbesselt R; Tjandra-Maga TB; Buntinx A; Distlerath L; De Schepper PJ
    Int J Clin Pharmacol Res; 1990; 10(3):167-71. PubMed ID: 2228341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhagic and thrombotic events associated with generic substitution of warfarin in patients with atrial fibrillation: a retrospective analysis.
    Ghate SR; Biskupiak JE; Ye X; Hagan M; Kwong WJ; Fox ES; Brixner DI
    Ann Pharmacother; 2011 Jun; 45(6):701-12. PubMed ID: 21666081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
    Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT
    Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.
    Haberer LJ; Walls CM; Lener SE; Taylor DR; McDonald SA
    Headache; 2010 Mar; 50(3):357-73. PubMed ID: 20132340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tolterodine on the anticoagulant actions and pharmacokinetics of single-dose warfarin in healthy volunteers.
    Rahimy M; Hallén B; Narang P
    Arzneimittelforschung; 2002; 52(12):890-5. PubMed ID: 12572529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lasofoxifene on the pharmacokinetics and pharmacodynamics of single-dose warfarin.
    Ouellet D; Bramson C; Carvajal-Gonzalez S; Roman D; Randinitis E; Remmers A; Gardner MJ
    Br J Clin Pharmacol; 2006 Jun; 61(6):741-5. PubMed ID: 16722839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioavailability of two dexamethasone tablet formulations in Indonesian healthy volunteers.
    Harahap Y; Sasongko L; Prasaja B; Indriati E; Lusthom W; Lipin
    Arzneimittelforschung; 2009; 59(4):191-4. PubMed ID: 19517895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.
    Schwartz JI; Bugianesi KJ; Ebel DL; De Smet M; Haesen R; Larson PJ; Ko A; Verbesselt R; Hunt TL; Lins R; Lens S; Porras AG; Dieck J; Keymeulen B; Gertz BJ
    Clin Pharmacol Ther; 2000 Dec; 68(6):626-36. PubMed ID: 11180023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.